# A Clinical Trial to Asses Efficacy and Safety of Cord Blood Eye Drops in Neurotrophic Keratopathy

> **NCT03084861** · PHASE1,PHASE2 · TERMINATED · sponsor: **Banc de Sang i Teixits** · enrollment: 9 (actual)

## Conditions studied

- Neurotrophic Keratopathy

## Interventions

- **DRUG:** Cord Blood Eye Drops
- **DRUG:** Conventional treatment

## Key facts

- **NCT ID:** NCT03084861
- **Lead sponsor:** Banc de Sang i Teixits
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-02-24
- **Primary completion:** 2020-03-12
- **Final completion:** 2020-03-12
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Low recruitment. No safety issue associated.
- **Last updated:** 2020-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03084861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03084861, "A Clinical Trial to Asses Efficacy and Safety of Cord Blood Eye Drops in Neurotrophic Keratopathy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03084861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*